GPT Healthcare shares make D-Street debut at 16% premium over issue price

GPT Healthcare is a healthcare company that owns and operates multispeciality neighbourhood tertiary care hospitals in India. The company's IPO (Initial Public Offering) was launched last week and raised Rs 525 crore at an issue price of Rs 1,000 per share. However, the shares made their D-Street debut at a premium of 16% over the issue price, meaning they were sold for Rs 1,160 per share.

The IPO was oversubscribed by 8.5 times, which means that there were more demand for shares than the number of shares available. This indicates strong investor interest in the company and its business model. GPT Healthcare operates a network of hospitals across India, providing a range of medical services to patients. The company's focus on neighbourhood tertiary care hospitals allows it to provide high-quality healthcare services to local communities at an affordable price.

The successful IPO and strong investor interest in GPT Healthcare is a positive sign for the Indian healthcare sector, which has been growing rapidly in recent years. The company's focus on providing quality healthcare services to local communities is likely to contribute to this growth and provide long-term opportunities for investors.